Sponsored content brought to you by
On February 26, 2021 the world of healthcare had a big reason to celebrate. As the number of reported COVID cases crept ever closer to 30 million in the United States, New Brunswick, NJ-based Johnson & Johnson officially got emergency approval from the FDA for its single-dose vaccination. It is the third vaccine to become authorized in the U.S., following the two-shot vaccines by Pfizer (that also has a significant footprint in New Jersey) and Moderna.
The news of the J&J vaccine was met with optimism, but it represents only part of the innovation that has occurred in New Jersey during the pandemic. Dozens of companies in New Jersey have made a difference during the past year, a true example of companies coming together at a time of unprecedented need.
The Approval of a Single Dose Vaccine
The United States FDA approved the Johnson &…
